Abstract:Since 1976 a clinical trial has been conducted to test the feasibility, the potential, and to develop methods for using the neutron‐emitting radioactive isotope, californium‐252 (Cf‐252), for the treatment of cervical cancer. A total of 218 patients were treated in the initial study period from 1976 until 1983. The trials initially treated advanced (Stages III and IV) cervical cancer patients using different doses and schedules; they were extended to include unfavorable presentations of Stages I and II because of favorable results in the initial trials. The authors began to treat patients with Stage IB bulky or barrel‐shaped tumors and the majority were treated with both radiation and hysterectomy. Actuarial survival was determined for Stage IB disease and was 87% at 5 years and 82% at 10 years. For those tested with preoperative radiation it was 92% at 5 and 87% at 10 years. For Stage II, it was 62% 5 years and 61% at 10. Survival 5 years after combined radiation and surgical therapy for Stage II disease was 68%. For Stage III, it was 33% at 5 years and 25% at 10. However, 5‐year survival using the early neutron implant was 46% versus approximately 19% for delayed Cf‐252 or cesium 137. Different schedules and sequences of neutrons and photons greatly altered outcome. Neutron treatment before external photon therapy was better for all stages of disease. Only about 5% of all patients developed complications after neutron therapy. No hematologic or mesenchymal second tumors were observed. Neutron brachytherapy was found to be very effective for producing rapid response and greatly improved local control of bulky, barrel, or advanced cervical cancers. The clinical trial identified and evolved schedules, doses, doses per session, and developed methods different from standard photon therapy but highly effective for local control and cure of cervical cancers of all stages. Clinical and radiobiologic understanding for the use of neutron therapy was greatly advanced by this trial. Future trials will focus on patients with advanced disease and will require evaluation of adjuvant chemotherapy studies and neutron‐enhancing chemicals.

Purification and Properties of 3-Deoxyglucosone Metabolizing Enzyme from S. Cerevisiae Y_(Br-M)

High level expression of a novel family 3 neutral β-xylosidase from Humicola insolens Y1 with high tolerance to D-xylose.

Structural and Functional Insights Into CmGH1, a Novel GH39 Family β-Glucosidase From Deep-Sea Bacterium.

Gene Cloning and Expression of a Glucoside 3-Dehydrogenase from Sphingobacterium Faecium ZJF-D6, and Used It to Produce N-p-nitrophenyl-3-ketovalidamine

Combination of Induced Autolysis and Sodium Hypochlorite Oxidation for the Production of Saccharomyces Cerevisiae (1 → 3)-Β-d-glucan

Screening of a Glucoside 3-Dehydrogenase-Producing Strain, Sphingobacterium faecium , Based on a High-Throughput Screening Method and Optimization of the Culture Conditions for Enzyme Production

Development of an industrial ethanol-producing yeast strain for efficient utilization of cellobiose.

Enzymatic Properties of Β-1,3-1,4-glucanase from Recombinant Industrial S. Cerevisiae

Remote sensing methods for surveying and extracting abandoned farmlands

A Novel Process for Preparation of (1→3)-Β-d-glucan Sulphate by a Heterogeneous Reaction and Its Structural Elucidation

Cloning, Expression and Characterization of A Glucose Dehydrogenase from Bacillus Sp G3 in Escherichia Coli

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

Purification and Some Properties of a Β-Glucanase from a Strain, Trichoderma Reesei GXC

A review of californium‐252 neutron brachytherapy for cervical cancer

Construction Of A Glucose And Xylose Co-Fermenting Industrial Saccharomyces Cerevisiae By Expression Of Codon-Optimized Fungal Xylose Isomerase

Purification and Characterization of a Xyloglucanase from Paenibacillus xylanilyticus

Functional diversity of family 3 β-glucosidases from thermophilic cellulolytic fungus Humicola insolens Y1

Purification and characterization of a highly selective glycyrrhizin-hydrolyzing β-glucuronidase from Penicillium purpurogenum Li-3

Optimization and purification of glucansucrase produced by Leuconostoc mesenteroides DRP2-19 isolated from Chinese Sauerkraut

Purification, Crystallization and Preliminary X-Ray Analysis of Glutathione Peroxidase Gpx3 from Saccharomyces Cerevisiae

Functional Characterization of Saccharomyces cerevisiae P5C Reductase, the Enzyme at the Converging Point of Proline and Arginine Metabolism